Dengue Literature Review

Dengue Neurological Complications

4 min read

Dengue Neurological Complications

Overview

Dengue virus can cause a range of neurological complications through three distinct pathways: (1) systemic or metabolic disturbances causing encephalopathy; (2) direct CNS invasion causing encephalitis, particularly by DENV-2 and DENV-3; and (3) autoimmunity-mediated complications, including Guillain–Barré syndrome (GBS) and acute disseminated encephalomyelitis (ADEM/autoimmune encephalomyelitis). Of these, ADEM is the most robustly documented at the population level, occurring within the first month of dengue illness.

Key Points from Literature

Neuropathogenesis: Three Pathways

From Guzman2016 - Dengue Infection and Shih2023 - Autoimmune Disease Risk After Dengue:

  1. Encephalopathy — altered consciousness from cerebral oedema (systemic vascular leakage), hepatic encephalopathy from dengue hepatitis, or metabolic disturbance; does not require direct CNS viral invasion.
  2. Encephalitis — direct DENV CNS invasion with viral detection in CSF; especially associated with DENV-2 and DENV-3; rarer than encephalopathy; can present as dengue encephalitis with fever, seizures, and CSF pleocytosis.
  3. Autoimmune-mediated — post-infectious syndromes in which molecular mimicry or non-specific activation of autoreactive T-cell clones against myelin or other self-antigens drives CNS or peripheral nervous system pathology; includes ADEM and GBS.

Autoimmune Encephalomyelitis (ADEM)

The most epidemiologically confirmed neurological complication of dengue. From Shih2023 - Autoimmune Disease Risk After Dengue:

  • In a population-based cohort of 63,814 lab-confirmed dengue patients, ADEM incidence was 1.53 per 10,000 person-years (dengue) vs. 0.54 (controls); aHR 2.72 (95% CI 1.84–4.02), P < 0.0001.
  • 16 dengue patients (0.025%) vs. 0 controls developed ADEM in the first month after symptom onset (HR >9999); risk was not significantly elevated thereafter.
  • Risk elevated in both sexes: males aHR 32 (P = 0.0010), females aHR 3.44 (P = 0.0001).
  • Reported onset of neurological symptoms in dengue-associated ADEM ranges from day 3 to day 19 after initial dengue symptoms, consistent with a post-infectious autoimmune mechanism.
  • ADEM is also known as postinfectious encephalomyelitis; the mechanism is a transient autoimmune response directed at myelin or other self-antigens — possibly via molecular mimicry or non-specific activation of autoreactive T-cell clones (see Infection-Triggered Autoimmunity).
  • Prior hospital-based meta-analysis estimated 0.4% of dengue patients develop ADEM — approximately 16× higher than the population-based estimate, reflecting the bias of hospital-only ascertainment toward severe presentations.
  • Other single-stranded RNA flaviviruses (West Nile virus, Zika, Chikungunya) are similarly reported to trigger autoimmune encephalomyelitis.

Guillain–Barré Syndrome (GBS)

  • Dengue is reported in case series as a trigger for GBS (post-infectious demyelinating polyneuropathy); multiple case reports have been described (see Guzman2016 - Dengue Infection).
  • However, in the Shih2023 population-based cohort study, the association was NOT statistically significant after correction for multiple testing (aHR 1.29; 95% CI 0.61–2.72; P = 0.5106).
  • Whether the case-report signal represents a true biological association at low incidence, or chance co-occurrence, remains uncertain. The incidence is too low for adequate power even in this large cohort (only 10 GBS cases in the dengue group).

Other Neurological Manifestations

From Guzman2016 - Dengue Infection:

  • Transitory Parkinsonism: rare, reversible parkinsonian features in the post-acute phase; mechanism unknown.
  • Dengue-related maculopathy: visual disturbance (blurring, scotoma) during or after dengue; associated with retinal haemorrhage and foveal oedema; may persist.
  • Dengue encephalopathy: altered consciousness from systemic causes; more common than encephalitis; does not require viral CNS invasion.

Serotype-Specific CNS Tropism

DENV-2 and DENV-3 are specifically implicated in direct CNS invasion leading to encephalitis (see Shih2023 - Autoimmune Disease Risk After Dengue, Guzman2016 - Dengue Infection). The mechanism likely involves differences in neurotropism encoded in NS proteins — consistent with the pattern that NS protein variation underlies differences in dengue tissue tropism and epidemic potential across serotypes.

Contradictions & Debates

  • The discrepancy between the 0.025% ADEM rate in Shih2023 and the 0.4% in prior meta-analysis is explained by case ascertainment: hospital-based studies capture only severe presentations, while this population-based study includes all outpatient and inpatient dengue. The true incidence in hospitalised dengue patients is expected to be higher than 0.025%.
  • GBS is biologically plausible as a dengue complication (molecular mimicry; see Infection-Triggered Autoimmunity; canonical example with C. jejuni), but the Shih2023 population-level analysis found no significant association. This may reflect insufficient statistical power (10 events) rather than absence of a true effect.
  • Data on serotype distribution was not available in Shih2023, preventing a definitive test of whether ADEM risk varies by serotype (e.g., DENV-2/3 > DENV-1/4).

Sources

Graph View

Backlinks